CellaVision AB (CEVI) - Financial and Strategic SWOT Analysis Review

Date: March 7, 2019
Pages: 47
Price:
US$ 125.00
License [?]:
Publisher: GlobalData
Report type: Company Report
Delivery: E-mail Delivery (PDF)
ID: C38AE77CB08EN
Leaflet:

Download PDF Leaflet

CellaVision AB (CEVI) - Financial and Strategic SWOT Analysis Review
CellaVision AB (CEVI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:
  • Business description – A detailed description of the company’s operations and business divisions.
  • Corporate strategy – Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history – Progression of key events associated with the company.
  • Major products and services – A list of major products, services and brands of the company.
  • Key competitors – A list of key competitors to the company.
  • Key employees – A list of the key executives of the company.
  • Executive biographies – A brief summary of the executives’ employment history.
  • Key operational heads – A list of personnel heading key departments/functions.
  • Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
  • Key manufacturing facilities – A list of key manufacturing facilities of the company.
  • Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights

CellaVision AB (CellaVision) is a medical technology company that provides digital solutions for medical microscopy in hematology. The company helps hematology laboratories improve and transform the analysis of blood and other body fluids. It has expertise in digital image analysis, automated microscopy and artificial intelligence. The company’s product portfolio includes analyzers for automated medical microscopy analysis; software applications such as CellaVision remote review software and CellaVision remote review software Citrix ready; proficiency software; and accessories such as CellaVision light tower, HemaPrep and barcode label printer kit. Through its global partners, CellaVision distributes its products in Europe, the Middle East and Africa (EMEA), Asia Pacific and North America. CellaVision is headquartered in Lund, Sweden.

CellaVision AB Key Recent Developments

Feb 07,2019: CellaVision
  • year-end bulletin, Jan-Dec 2018
    Oct 23,2018: CellaVision: Interim report January-September 2018
    Oct 09,2018: CellaVision AB pesents the third quarter 2018 on October 23 at 11:00 CET
    Jul 17,2018: CellaVision: Interim Report January-June 2018
    May 03,2018: CellaVision: Interim report January-March 2018

    Key benefits of buying this profile include:

    You get detailed information about the company and its operations to identify potential customers and suppliers.
    • The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
    Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
    • The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
    Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
    • Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
    Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
    • Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
    Gain key insights into the company for academic or business research.
    • Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
    Note: Some sections may be missing if data is unavailable for the company

    NOTE: Out of security concerns GlobalData requires using corporate email address.
  • SECTION 1 - ABOUT THE COMPANY

    CellaVision AB - Key Facts
    CellaVision AB - Key Employees
    CellaVision AB - Key Employee Biographies
    CellaVision AB - Major Products and Services
    CellaVision AB - History
    CellaVision AB - Company Statement
    CellaVision AB - Locations And Subsidiaries
    Head Office
    Other Locations & Subsidiaries

    SECTION 2 – COMPANY ANALYSIS

    Company Overview
    CellaVision AB - Business Description
    Product Category: Instruments
    Performance
    Product Category: Other
    Performance
    Geographical Segment: APAC
    Performance
    Geographical Segment: EMEA
    Performance
    Geographical Segment: The Americas
    Performance
    R&D Overview
    CellaVision AB - Corporate Strategy
    CellaVision AB - SWOT Analysis
    SWOT Analysis - Overview
    CellaVision AB - Strengths
    CellaVision AB - Weaknesses
    CellaVision AB - Opportunities
    CellaVision AB - Threats
    CellaVision AB - Key Competitors

    SECTION 3 – COMPANY FINANCIAL RATIOS

    Financial Ratios - Capital Market Ratios
    Financial Ratios - Annual Ratios
    Performance Chart
    Financial Performance
    Financial Ratios - Interim Ratios
    Financial Ratios - Ratio Charts

    SECTION 4 – COMPANY’S LIFESCIENCES FINANCIAL DEALS AND ALLIANCES

    CellaVision AB, Medical Equipment, Deals By Year, 2013 to YTD 2019
    CellaVision AB, Medical Equipment, Deals By Type, 2013 to YTD 2019
    CellaVision AB, Recent Deals Summary

    SECTION 5 – COMPANY’S RECENT DEVELOPMENTS

    Feb 07, 2019: CellaVision- year-end bulletin, Jan-Dec 2018
    Oct 23, 2018: CellaVision: Interim report January-September 2018
    Oct 09, 2018: CellaVision AB pesents the third quarter 2018 on October 23 at 11:00 CET
    Jul 17, 2018: CellaVision: Interim Report January-June 2018
    May 03, 2018: CellaVision: Interim report January-March 2018
    Apr 17, 2018: CellaVision: The Nomination Committee of CellaVision supplements its proposal with an additional Board member
    Feb 09, 2018: CellaVision Year-end Bulletin 2017

    SECTION 6 – APPENDIX

    Methodology
    Ratio Definitions
    About GlobalData
    Contact Us
    Disclaimer

    LIST OF TABLES

    CellaVision AB, Key Facts
    CellaVision AB, Key Employees
    CellaVision AB, Key Employee Biographies
    CellaVision AB, Major Products and Services
    CellaVision AB, History
    CellaVision AB, Other Locations
    CellaVision AB, Subsidiaries
    CellaVision AB, Key Competitors
    CellaVision AB, Ratios based on current share price
    CellaVision AB, Annual Ratios
    CellaVision AB, Annual Ratios (Cont.1)
    CellaVision AB, Annual Ratios (Cont.2)
    CellaVision AB, Interim Ratios
    CellaVision AB, Medical Equipment, Deals By Year, 2013 to YTD 2019
    CellaVision AB, Medical Equipment, Deals By Type, 2013 to YTD 2019
    CellaVision AB, Recent Deals Summary
    Currency Codes
    Capital Market Ratios
    Equity Ratios
    Profitability Ratios
    Cost Ratios
    Liquidity Ratios
    Leverage Ratios
    Efficiency Ratios

    LIST OF FIGURES

    CellaVision AB, Performance Chart (2014 - 2018)
    CellaVision AB, Ratio Charts
    CellaVision AB, Medical Equipment, Deals By Year, 2013 to YTD 2019
    CellaVision AB, Medical Equipment, Deals by Type, 2013 to YTD 2019

    COMPANIES MENTIONED

    Analyticon Biotechnologies AG
    Biotage AB
    Circassia AB
    ContextVision AB
    Skip to top


    Hyperthyroidism Global Clinical Trials Review, H1, 2018 US$ 2,500.00 May, 2018 · 69 pages

    Ask Your Question

    CellaVision AB (CEVI) - Financial and Strategic SWOT Analysis Review
    Company name*:
    Contact person*:
    Phone/fax*:
    Email*:
    Request invoice
    Your enquiry:
    Please click on a Check Box below to confirm you are not a robot: